Blood Tests Before Steroids: 7 Markers to Check
Blood Tests Before Steroids: 7 Key Markers to Check First
Steroid blood work before a cycle comes down to seven panels: a CBC for hematocrit, a fasting lipid panel, liver enzymes, kidney markers, hormones, fasting glucose with HbA1c, and blood pressure. The thresholds are not theoretical: a 2023 European Urology Focus consultation guide reduces or stops testosterone once hematocrit passes 54 percent (PMID 36335038), and AAS reliably lower HDL and raise LDL (PMID 31478927). Blood tests before steroids give you the baseline every on-cycle reading is judged against. This guide covers what bodybuilding blood work should include, the normal ranges for each marker, and the mistakes that make the panel useless.
Blood Tests Before Steroids: 7 Markers to Check
If you're planning a steroid cycle, blood tests before steroids are not optional - they're the clinical foundation of every informed approach to performance pharmacology. A 2024 clinical practice guideline published in the British Journal of General Practice identifies essential pre-cycle bloodwork as the minimum standard for any patient using androgenic anabolic steroids.
Running blood tests before steroids takes one lab visit and 48 hours of waiting. Skipping them means you have no baseline to compare against, no way to know whether any adverse changes during your cycle are caused by the compound or were already present, and no data to guide your post-cycle recovery. This guide covers all 7 marker categories, their reference ranges, why each changes with AAS use, and what findings should delay your start.
Marker Categories
Before Cycle Start
Verified References
Why Blood Tests Before Steroids Can't Be Skipped
Anabolic androgenic steroids affect multiple organ systems simultaneously. A prospective cohort study following 100 men through a full androgen cycle documented significant changes across blood pressure, lipid metabolism, and erythrocytosis that largely reversed within roughly three months of stopping the cycle. Without a pre-cycle baseline, you cannot distinguish a drug-induced change from a pre-existing condition - and that distinction determines whether you need a physician, a protocol adjustment, or simply continued monitoring.
The practical case for blood tests before steroids comes down to three things: establishing your personal reference point (standard lab ranges don't reflect your individual normal), identifying conditions that contraindicate starting - elevated liver enzymes, existing polycythemia, or severe dyslipidemia all require resolution before any cycle - and giving you the data to compare against your on-cycle and post-cycle panels.
Priority level by marker - pre-cycle blood testing protocol (wider bar = higher priority)
Priority ratings based on Br J Gen Pract 2024 clinical guidelines and European Urology Focus 2023 consultation framework. Critical = organ damage likely without baseline; High = clinically significant changes expected; Moderate = monitoring recommended.
Complete Blood Count: Your Hematocrit Baseline
The CBC (complete blood count) is one of the most critical panels to include in any blood tests before steroids protocol. AAS - including testosterone - are potent stimulators of erythropoiesis, meaning they drive the production of red blood cells. Without a pre-cycle baseline, you cannot know whether an elevated hematocrit during or after your cycle was induced by the compound or was already present.
Clinical threshold: Hematocrit above 54% requires dose reduction or temporary discontinuation, per European Urology Focus 2023 guidelines. A baseline reading near the top of normal range (48%+) signals elevated risk before the cycle even begins.
Hematocrit - the critical threshold is 54%
Normal range for men is 38.3-48.6%. A European Urology Focus clinical consultation guide (2023) specifies that providers should reduce or discontinue testosterone therapy if hematocrit exceeds 54% until values normalize. This same threshold applies during AAS use. When you get blood tests before steroids, your baseline hematocrit tells you how much room you have before reaching this clinical danger zone.
A large multicenter study using a database of 74 million patients found that secondary polycythemia during testosterone therapy significantly increased risk of major adverse cardiovascular events (MACE) and venous thromboembolism within the first year. Knowing your pre-cycle baseline is what makes ongoing monitoring actionable.
Hemoglobin - check alongside hematocrit
Normal hemoglobin in men is 13.5-17.5 g/dL. AAS elevate both hematocrit and hemoglobin in parallel. If your baseline hemoglobin is already near the top of range (16.5-17.5 g/dL), even modest AAS-induced elevation can push you into erythrocytosis territory faster than average. This makes pre-cycle hemoglobin measurement an important part of blood tests before steroids.
Red Blood Cell Count (RBC) and MCV
Baseline RBC (normal: 4.35-5.65 million/µL in men) and mean corpuscular volume (MCV, normal 80-100 fL) complete the erythrocyte picture. Macrocytosis visible on the CBC can point to pre-existing conditions that AAS may worsen. See our dedicated guide on hematocrit and hemoglobin markers for full interpretation.
Fasting Lipid Panel: LDL, HDL, and Triglycerides
The lipid panel is the single highest-priority item in any blood tests before steroids panel. A 2019 review published in the Chinese Medical Journal confirmed that AAS induce lipid metabolism disorder characterized by decreased HDL and increased LDL - a pattern directly linked to accelerated atherosclerosis and elevated cardiovascular risk. The magnitude of these changes varies by compound, dose, and route, but nearly all AAS affect lipids to some degree. Oral 17-alpha alkylated steroids typically cause the most dramatic shifts.
Your pre-cycle lipid profile sets the starting point. If you begin a cycle with LDL already at 130 mg/dL and AAS drives it to 180 mg/dL, that context matters clinically. Without the baseline, you're comparing against population averages rather than your own normal. Run your lipid panel fasted (10-12 hours) for accurate triglyceride measurement.
| Marker | Optimal | Borderline | Clinical Concern |
|---|---|---|---|
| LDL Cholesterol | <100 mg/dL | 100-129 mg/dL | ≥130 mg/dL |
| HDL Cholesterol (men) | ≥60 mg/dL | 40-59 mg/dL | <40 mg/dL |
| Triglycerides | <150 mg/dL | 150-199 mg/dL | ≥200 mg/dL |
| Total Cholesterol | <200 mg/dL | 200-239 mg/dL | ≥240 mg/dL |
If your pre-cycle lipid panel shows LDL above 130 mg/dL or HDL below 40 mg/dL, that is a meaningful risk multiplier that should be addressed before you begin. See the full guide on the lipid panel before steroids for compound-specific lipid effects.
Liver Markers: AST, ALT, and GGT Baseline
Liver enzyme testing is a mandatory component of blood tests before steroids. A 2015 study published in Alimentary Pharmacology & Therapeutics analyzed 25 cases of AAS-associated drug-induced liver injury (DILI) and identified a distinct hepatotoxicity phenotype with a prolonged cholestatic pattern - different from medication-induced liver injury. The baseline matters because elevated liver enzymes before a cycle can indicate pre-existing conditions, and cycle-induced further elevation may reach hepatotoxic thresholds much faster in someone who starts above normal.
Why GGT matters: While AST and ALT are the standard liver markers, GGT is uniquely sensitive to cholestatic damage - the type most associated with oral AAS. Adding GGT to your panel catches liver stress that ALT alone can miss.
ALT (Alanine Aminotransferase) - the liver-specific marker
Normal range: 7-56 U/L for men. ALT is the most liver-specific of the standard markers. Elevations above 3× the upper limit of normal (3× ULN) are the clinical threshold for significant hepatocellular injury. Oral 17-alpha alkylated steroids (oxandrolone, stanozolol, oxymetholone) carry the highest hepatotoxic risk; injectable esters (testosterone enanthate/cypionate, nandrolone) are significantly less hepatotoxic at therapeutic doses.
AST (Aspartate Aminotransferase) - interpret carefully in athletes
Normal range: 10-40 U/L. Important caveat for your blood tests before steroids: AST is not liver-specific. It is also released by muscle tissue during exercise. A bodybuilder training hard may show AST of 60-90 U/L entirely from skeletal muscle damage, with no liver involvement. If your AST is elevated pre-cycle, check whether CK (creatine kinase) is also elevated - if both are high and ALT is normal, this is muscle-origin AST, not hepatic. See the guide on why CK is elevated for full context.
GGT (Gamma-Glutamyl Transferase)
Normal range: 9-48 U/L. GGT is more specific to biliary and hepatic origin than AST. Elevated GGT alongside elevated ALT confirms hepatic rather than muscular enzyme elevation. Including GGT in your blood tests before steroids panel helps correctly interpret the AST/ALT pattern. Full breakdown in the liver markers guide.
Kidney Markers: Creatinine, eGFR, and BUN
Kidney markers present a unique interpretive challenge in the context of blood tests before steroids. A 2023 study in Cureus (24 bodybuilders) examining AAS users found that creatinine-based eGFR can underestimate true kidney function in this population - increased muscle mass produces more creatinine baseline, leading standard reference ranges to flag normal bodybuilder values as abnormal.
The same study noted that cystatin C equations provide more accurate GFR estimation in athletes, though most labs default to creatinine-based calculations. In that same small study, cystatin C-based eGFR was actually significantly lower in AAS users - alongside higher urinary albumin and protein - a signal of early kidney stress that creatinine alone can mask, so a normal creatinine-based eGFR should not be read as an all-clear.
Despite the interpretive complexity, establishing a pre-cycle baseline is still essential. AAS have been associated with focal segmental glomerulosclerosis (FSGS) - irreversible scarring of the kidney filtration units - and a systematic review published in BMC Nephrology (2019) identified multiple pathways through which AAS and growth hormone can compromise renal safety. If you have pre-existing kidney impairment, any AAS protocol requires medical supervision.
Where People Go Wrong With Pre-Cycle Blood Testing
The most common error with blood tests before steroids is simply not getting them. The second most common is getting them wrong - at the wrong time, with the wrong panel, or interpreting the results against population ranges rather than athletic context. Here are the four mistakes that produce useless or misleading baseline data.
Testing too close to your start date
Testing too close to your start date
Blood tests before steroids should be run at least two weeks before your planned cycle start - ideally four. This leaves time to investigate abnormal findings, repeat tests if values seem inconsistent, or delay the cycle if a pre-existing issue is uncovered. Testing three days before you start and then proceeding regardless makes the baseline essentially useless.
Ordering only what your primary care doctor recommends
Ordering only what your primary care doctor recommends
A standard annual physical panel often omits LH, FSH, estradiol, and GGT - markers that are essential for complete pre-cycle assessment. When getting , order a full lipid panel (not just total cholesterol), a complete metabolic panel (CMP), CBC with differential, a hormone panel including testosterone/LH/FSH/E2, and HbA1c. Many men use direct-to-consumer lab services to get complete panels without needing a prescription.
Interpreting AST elevation as liver damage without context
Interpreting AST elevation as liver damage without context
Seeing an elevated AST on pre-cycle and concluding your liver is damaged is a very common error. In athletes, elevated AST is frequently of muscular origin. Always check CK and GGT alongside AST. If CK is elevated and ALT/GGT are normal, the AST is coming from muscle, not liver. The distinction matters clinically and changes what further workup is needed.
Not retesting during and after your cycle
Not retesting during and after your cycle
The pre-cycle panel is only one part of a complete and monitoring protocol. Plan to retest at weeks 4-6 of a cycle, at cycle end, and at 4-6 weeks post-cycle during PCT. The post-cycle panel is what confirms HPTA recovery and identifies residual lipid or hematological changes that require continued management. See the full bloodwork monitoring guide for timing recommendations.
Steroid Blood Work FAQ: Blood Tests Before Steroids
These are the questions most commonly asked about blood tests before steroids, based on clinical consultation data and community feedback. Each answer reflects current evidence and published clinical guidelines.
When should I get blood tests before steroids?
What are the most important blood tests before a steroid cycle?
Do I need blood tests before steroids even for a first cycle?
Can blood tests before steroids detect whether someone will tolerate a cycle well?
What if my blood tests before steroids show abnormal results?
What bloodwork do bodybuilders get before a cycle?
Do steroids affect blood test results?
Where can I get blood work done for steroids?
Medical References and Bloodwork Sources
All clinical data cited in this guide on blood tests before steroids comes from peer-reviewed literature. Each reference below has been physically verified via PubMed. No citations are sourced from memory or assumed - each PMID links to the indexed abstract.
Explore the Bloodwork Cluster
Each guide below goes deep on one marker category from this pre-cycle protocol. All are PMID-verified and written for performance-focused readers who want the clinical data, not generalities.
Final Educational Note
This article is published for educational purposes only. It presents a protocol-level overview of blood tests before steroids based on published peer-reviewed research and clinical practice guidelines. Nothing in this article constitutes medical advice, a diagnosis, or a recommendation to use any substance. MuscleScience.org does not advocate for, condone, or facilitate anabolic steroid use. All content is intended to provide factual, evidence-based information for educational purposes to readers who seek to understand the clinical data on this topic.
Reference ranges cited represent general adult male population standards. Individual variation is significant, and all laboratory results should be interpreted in consultation with a qualified physician who has access to your full medical history. If your pre-cycle blood work reveals abnormal values, consult a healthcare provider before making decisions about any protocol. Next steps: how often to get bloodwork on a cycle and do steroids damage your liver.
